ferroquine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
Cambodia is the epicentre of resistance emergence for virtually all antimalarial drugs. Selection and spread of…
Artemisinin-based combination therapies are recommended as first-line agents for treating uncomplicated Plasmodium falciparum…
Hepatitis C virus (HCV) is a major cause of chronic liver disease. Despite recent success in improving anti‐HCV therapy…
ABSTRACT Ferroquine (SSR97193), a ferrocene-quinoline conjugate, is a promising novel antimalarial currently undergoing clinical…
BackgroundThe development and spread of drug resistant Plasmodium falciparum strains is a major concern and novel anti-malarial…
Ferroquine (FQ), a chloroquine (CQ) analog, is being developed to treat persons with Plasmodium falciparum malaria. In 146 P…
ABSTRACT The novel organometallic chloroquine analog ferroquine (SSR 97193) is effective against chloroquine-resistant…
A malaria e uma doenca parasitaria que aflige aproximadamente 500 milhoes de pessoas e causa mais de um milhao de mortes por ano…
Ferroquine (SSR97193) has been shown to be a promising antimalarial, both on laboratory clones and on field isolates. So far, no…
Ferroquine (FQ) is a new antimalarial agent with a high blood schizotoncidal activity. Previous studies on this compound were…